Table 3:

3- and 5-year absolute risks of CIN3 and CIN2+, following one, two and three negative cotests, adjusted for unresolved positive results^{^}

	N	3-year risk of CIN3		5-year risk of CIN3		3-year risk of CIN2+		5-year risk of CIN2+
		Absolute risk	95% CI	Absolute risk	95% CI	Absolute risk	95% CI	Absolute risk	95% CI
One negative co-test	174,205	0.025%	(0.014, 0.036)	0.034%	(0.023, 0.046)	0.061%	(0.037, 0.085)	0.128%	(0.101, 0.155)
Two negative co-tests	63,813	0.010%	(0.000, 0.025)	0.041%	(0.007, 0.076)	0.040%	(0.019, 0.062)	0.092%	(0.045, 0.139)
Three negative co-tests*	10,549	0.016%	(0.000, 0.052)	0.016%	(0.000, 0.052)	0.016%	(0.000, 0.052)	0.016%	(0.000, 0.052)

Confidence intervals are based on bootstrapping. No women were diagnosed with invasive cervical cancer

^*Based on one observed event

^{^}Assuming women with unresolved positive results are missing at random given their positive result, see Supplementary Materials 2 for details